Biologics Regulatory Cerapedics Announces FDA approval of an IDE supplement byJosh SandbergJuly 22, 2020
Biologics Spine Cerapedics Announces Results from Clinical Trial of i-FACTOR® Peptide Enhanced Bone Graft in Lumbar Fusion Surgery byJosh SandbergMay 19, 2020
Biologics Regulatory Spine Cerapedics Announces FDA Approval of PMA Supplement Based on Two-Year Clinical Data byJosh SandbergNovember 18, 2019
Biologics OSN Premium OSP Insider Cerapedics Announces Expansion of Colorado Headquarters byJosh SandbergJuly 8, 2019
Biologics Cerapedics Appoints Patrick O’Connor as Vice President of Clinical and Market Development byJosh SandbergJune 24, 2019
Biologics Cerapedics Announces ISASS Issued a new Bone Grafting Policy Statement that Features i-FACTOR™ Peptide Enhanced Bone Graft byJosh SandbergMarch 6, 2019
Biologics Cerapedics Announces First Patients Enrolled in IDE Clinical Trial of P-15L Bone Graft for Transforaminal Lumbar Interbody Fusion Surgery byJosh SandbergJuly 30, 2018
Biologics Top Stories Cerapedics Receives 2018 MedTech Breakthrough Award for Best New Surgical Technology Solution byJosh SandbergJune 13, 2018
Biologics Top Stories Cerapedics Announces Presentation of Results from the IVANOS Study of i-FACTOR™ Peptide Enhanced Bone Graft in Uninstrumented Lumbar Posterolateral Spine Surgery byJosh SandbergMay 21, 2018
